Results from early-stage clinical trials show two drugs that target the DNA damage response (DDR) pathway in cancers—ATR inhibitor elimusertib and PARP inhibitor AZD5305—are safe and […]
Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American […]
We’re all familiar with the classic “look” of a movie bad guy: peering through narrowing eyes with a sinister sneer (like countless James Bond villains, including […]